Many Americans won't benefit from Eli Lilly's insulin price cut

When drugmaker Eli Lilly announced it was slashing the cost of insulin and capping out-of-pocket costs to just $35 a month, it was major news.

Related Keywords

United States ,California ,Washington ,Americans ,Michael Greiner ,Nicole Gambino ,Eli Lilly ,Brandon Karmo ,Oakland University ,Greiner ,Novo Nordisk ,